Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

被引:194
|
作者
Winter, Jordan M. [1 ]
Yeo, Charles J. [1 ]
Brody, Jonathan R. [1 ]
机构
[1] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA
关键词
pancreatic cancer; pancreatic ductal adenocarcinoma; biomarkers; predictive markers; prognostic markers; SERUM CA-19-9 LEVELS; GENE-EXPRESSION; ADJUVANT CHEMOTHERAPY; PHOSPHOGLYCERATE KINASE-1; DUCTAL ADENOCARCINOMA; CA19-9; LEVELS; SURVIVAL; GEMCITABINE; RECURRENCE; IDENTIFICATION;
D O I
10.1002/jso.23192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Serum CA 19-9 is the only FDA approved biomarker recommended for use in the routine management of pancreatic ductal adenocarcinoma (PDA). Over 2,000 biomarker studies related to pancreatic cancer appear in the literature, highlighting the need to discover and develop improved tests. Diagnostic biomarkers have implications for early detection of PDA, prognostic markers predict patient survival and recurrence patterns, and predictive markers can help personalize treatment regimens. J. Surg. Oncol. 2013;107:1522. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [41] Diagnostic and prognostic epigenetic biomarkers in cancer
    Costa-Pinheiro, Pedro
    Montezuma, Diana
    Henrique, Rui
    Jeronimo, Carmen
    EPIGENOMICS, 2015, 7 (06) : 1003 - 1015
  • [42] Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
    Cheng, Yang
    Wang, Kunyuan
    Geng, Lanlan
    Sun, Jingjing
    Xu, Wanfu
    Liu, Dingli
    Gong, Sitang
    Zhu, Yun
    EBIOMEDICINE, 2019, 40 : 382 - 393
  • [43] Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer
    Carlomagno, Nicola
    Incollingo, Paola
    Tammaro, Vincenzo
    Peluso, Gaia
    Rupealta, Niccolo
    Chiacchio, Gaetano
    Sotelo, Maria Laura Sandoval
    Minieri, Gianluca
    Pisani, Antonio
    Riccio, Eleonora
    Sabbatini, Massimo
    Bracale, Umberto Marcello
    Calogero, Armando
    Dodaro, Concetta Anna
    Santangelo, Michele
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [44] Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
    Beibei Chen
    Huan Zhao
    Huihui Hu
    Haili Shang
    Hui Wang
    Zhentao Yao
    Jinxi Huang
    Huifang Lv
    Weifeng Xu
    Jianzheng Wang
    Caiyun Nie
    Jing Zhao
    Yunduan He
    Saiqi Wang
    Xiaobing Chen
    Scientific Reports, 15 (1)
  • [45] Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer
    Marin, Anelis Maria
    Batista, Michel
    de Azevedo, Alexandre Luiz Korte
    Gomig, Talita Helen Bombardelli
    Brant, Rodrigo Soares Caldeira
    Chammas, Roger
    Uno, Miyuki
    Araujo, Diogo Dias
    Zanette, Dalila Luciola
    Aoki, Mateus Nobrega
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [46] CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
    Arehibugi, Livia
    Pisani, Ruggero Ponz De Leon
    Sattin, Eleonora
    Bertoldi, Loris
    Rossi, Gemma
    Mariani, Alberto
    Valle, Giorgio
    Arcidiacono, Paolo G.
    Capurso, Gabriele
    GASTROENTEROLOGY, 2022, 162 (07) : S907 - S907
  • [47] Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
    Li, Le
    Zhang, Guang-Quan
    Chen, Hua
    Zhao, Zhong-Jie
    Chen, Hong-Ze
    Liu, Huan
    Wang, Gang
    Jia, Yue-Hui
    Pan, Shang-ha
    Kong, Rui
    Wang, Yong-Wei
    Sun, Bei
    ONCOTARGET, 2016, 7 (44) : 71773 - 71781
  • [48] CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
    Archibugi, L.
    Pisani, Ponz De Leon R.
    Sattin, E.
    Bertoldi, L.
    Rossi, G.
    Mariani, A.
    Valle, G.
    Arcidiacono, P. G.
    Capurso, G.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S68 - S68
  • [49] Predictive biomarkers to metastatic pancreatic cancer treatment
    Goldstein, J. B.
    Overman, M.
    Varadhachary, G.
    Shroff, R.
    Wolff, R.
    Javle, M.
    Futreal, A.
    Fogelman, D.
    HUMAN GENOMICS, 2016, 10
  • [50] Update on prognostic and predictive biomarkers of breast cancer
    Hou, Yanjun
    Peng, Yan
    Li, Zaibo
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2022, 39 (05) : 322 - 332